Zymeworks Shares up 4.1% Premarket After FDA Clears Co's Application to Start Trials in Humans for Cancer Drug
zymeworks股票在FDA批准該公司申請開始人類腫瘤藥物試驗後,盤前上漲4.1%
Zymeworks Shares up 4.1% Premarket After FDA Clears Co's Application to Start Trials in Humans for Cancer Drug
zymeworks股票在FDA批准該公司申請開始人類腫瘤藥物試驗後,盤前上漲4.1%
譯文內容由第三人軟體翻譯。